AbCro, a novel transcription factor, promotes biofilm formation and virulence in Acinetobacter baumannii Authors: Cuicui Liu, Ao Qin, Jun Xie, Mingpeng Fu, Chengfeng Gao, Juan Wu, Junling Wang, Jingchen Hao, Ting Yu, Wenjie Yuan, Jian Hu, Weixuan Yang, Guocai Li Published: 2026 ABSTRACT AbstractBackgroundThe emergence of highly virulent Acinetobacter baumannii strains has increased patient mortality and complicated clinical prognosis, motivating the development of novel control strategies.ResultsGenomic analysis of the clinical isolate AB43 revealed a protein, AbCro, which is homologous to the bacteriophage transcription factor Cro. In this study, an Abcro deletion mutant and its complemented strain were constructed. Our results showed that the deletion of Abcro significantly reduced the biofilm formation, attenuated virulence in both Galleria mellonella and mice, and alleviated pathological damage to lung tissues in mice. Transcriptome analysis revealed that the expression of both otsA and otsB was significantly downregulated in the AB43Δcro strain. These genes encode trehalose-6-phosphate synthase (OtsA) and trehalose-6-phosphate phosphatase (OtsB), respectively, which sequentially catalyze trehalose biosynthesis - a key stress protectant in microorganisms. The otsA was located 3’ to the otsB and the genes overlapped by 13 nucleotides, forming the otsBA operon. The purified AbCro was able to bind to the promoter region of the operon.ConclusionsThese results demonstrate that AbCro may activate the trehalose biosynthesis pathway otsBA, consequently enhancing the virulence of A. baumannii. Altogether, these findings provide novel theoretical foundations and potential therapeutic targets for controlling A. baumannii infections.Supplementary InformationThe online version contains supplementary material available at 10.1186/s12866-026-05022-7.Keywords: Acinetobacter baumannii, transcription factor, virulence Introduction Acinetobacter baumannii is a Gram-negative bacterium primarily recognized as an opportunistic pathogen in hospital settings, where it is particularly associated with a wide range of nosocomial infections [1]. Clinical manifestations include pneumonia, bacteremia, and infections of the abdominal cavity, central nervous system, urinary tract, skin, and soft tissues. Notably, this pathogen poses a serious threat in intensive care units (ICUs), often leading to ICU-acquired infections and complicating the management of critically ill patients [2, 3]. The genomic plasticity of A. baumannii enables it to rapidly mutate and adapt to environmental stresses [4, 5], resulting in the increased emergence of highly drug-resistant and/or virulent A. baumannii strains. The emergence of drug-resistant strains has posed significant challenges to clinical therapy. To address this challenge, research efforts are directed toward two key strategies, developing treatments targeting resistance mechanisms [6], and inhibiting bacterial virulence to attenuate pathogenicity as a promising alternative approach. Therefore, a comprehensive understanding of the virulence and pathogenic mechanisms of A. baumannii is thus crucial for developing innovative strategies to prevent and control bacterial infections in hospital settings. In recent years, significant progress has been made in understanding the virulence determinants of A. baumannii. Major virulence factors include those involved in adherence (Ata, TFP) [7, 8] and invasion (T2SS, T6SS) [9, 10], toxin production (phospholipase C, phospholipase D, CpaA) [11–13], immune evasion mechanisms (capsule, LPS, ompA, pbpG) [14–17], biofilm formation (adeFGH efflux pump, Bap, Csu fimbriae, PNAG, Quorum sensing) [18–22], and nutritional acquisition (Acinetobactin, HemO cluster) [23, 24]. Trehalose metabolism plays multiple critical roles in bacterial pathogenicity that extend beyond osmotic regulation. Studies have demonstrated that disrupting this metabolic pathway can effectively attenuate the virulence of various pathogens. For instance, in Mycobacterium tuberculosis and Burkholderia pseudomallei, the disruption of this pathway has been directly validated through in vivo infection models such as mice and insects, leading to a significant reduction in colonization and pathogenic capacity [25]. In the opportunistic pathogen A. baumannii, deficiency in trehalose synthesis not only completely abolishes its virulence in a Galleria mellonella larval infection model [26] but also mechanistically induces severe impairment of core virulence phenotypes, including loss of capsular polysaccharide, sharply increased sensitivity to host serum complement killing and macrophage phagocytosis, and significantly reduced tolerance to environmental desiccation [26, 27]. Collectively, this evidence reveals that trehalose serves as a crucial metabolic hub for maintaining bacterial host adaptability and immune evasion capabilities, thereby representing a promising anti-virulence therapeutic target. Consequently, interventions designed to genetically modulate these virulence determinants represent a novel therapeutic paradigm for combating A. baumannii infections. Among diverse virulence regulatory mechanisms, phage-mediated lysogenic conversion serves as a pivotal evolutionary driver, enabling bacteria to acquire novel virulence genes and regulatory elements [28]. This is compellingly illustrated by the fact that many renowned bacterial virulence factors, such as diphtheria and cholera toxins, are encoded by phage-derived genes [28]. The bacteriophage-derived Cro protein has been demonstrated to function as a global transcription factor that directly regulates virulence genes in Enterohemorrhagic E. coli [29, 30]. The AbCro identified in this study, which is homologous to the bacteriophage transcription factor Cro, suggests that A. baumannii may have acquired a sophisticated gene regulatory tool through the integration of prophage DNA. To investigate the specific function and mechanism of the phage-derived protein AbCro in the pathogenicity of A. baumannii, this study constructed a deletion mutant and conducted phenotypic and transcriptomic analyses. We found that knockout of transcription factor AbCro in A. baumannii resulted in reduced biofilm formation ability and virulence, with complementary strains and wild-type strains exhibiting consistent performance. Further studies explored the molecular mechanism by which transcription factor AbCro regulates the virulence of A. baumannii. Materials and methods Bacterial strains and culture conditions The clinical A. baumannii strain AB43 was isolated from the affiliated hospital of Yangzhou University in Jiangsu, China [31]. The bacterial strains and primers used in this study are detailed in Table S1. Bacterial strains were routinely cultured in LB broth or on LB agar (1.5% w/v) at 37 °C. For E. coli strains harboring plasmids, the medium was supplemented with tetracycline (15 µg/ml), kanamycin (50 µg/ml), or carbenicillin (100 µg/ml) as appropriate. Following electroporation, A. baumannii transformants were selected on LB agar plates containing the corresponding antibiotic. Generation of Abcro knockout and Abcro-complemented strains The Abcro-deficient strain of A. baumannii AB43Δcro was constructed according to previously reported methods [32]. In brief, the genome of A. baumannii AB43 and the plasmid pKD4 were used as templates. We constructed the upstream and downstream homologous arms (each approximately 200 bp) of the Abcro (GenBank accession number K9O37_RS10835), along with a kanamycin resistance cassette flanked by FRT sites, for use in the gene knockout. Single colonies were selected on kanamycin-containing LB agar plates and verified by PCR using specific primers. To construct the mutant strain AB43Δcro, the kanamycin resistance gene was first flanked by FRT sites and subsequently excised using FLP recombinase. For the complemented strain, the Abcro was amplified from A. baumannii and cloned into the plasmid pMMB67EH, resulting in the recombinant plasmid pMMB67EH-cro. The plasmid was then transformed into the AB43Δcro strain, and the correct recombinant clones were screened and verified by PCR using primers pMMB67EH‑F and pMMB67EH‑R. The Abcro in the recombinant plasmid pMMB67EH-cro is expressed under the control of the Ptac promoter of the vector. Determination of growth curves Overnight cultures of AB43WT, AB43WT/empty pvector, AB43Δcro, AB43Δcro/empty pvector and AB43Δcro/pcro were subcultured at a 1:100 ratio into fresh LB broth and incubated in 96-well plates at 200 µl per well with shaking at 37℃, with four replicate wells for each strain. The LB medium without bacterial addition served as the blank control group. The optical density at 600 nm (OD600) of the bacterial culture samples was measured every 0.5 h from 0 to 24 h using a multifunctional microplate reader (SPARK instrument). Growth curves were plotted using time as the horizontal coordinate and OD600 values as the vertical coordinate. Biofilm formation assay Biofilm formation was quantified using the crystal violet staining method, as previously described [33]. In brief, bacterial cultures were grown to an OD₆₀₀ of 0.5 under shaking conditions at 37 °C, then diluted 1:100 and dispensed into 96-well plates (200 µl per well). Plates were incubated statically at 37 °C for 48 h to allow biofilm development. The bacterial solution was washed three times with PBS. After the 96-well plate was air-dried, the biofilm was stained with 4% crystal violet (Solarbio) for 30 min in the dark. The staining solution was then discarded, and the plate was washed three times with PBS to remove unbound dye. Finally, the crystal violet was dissolved with 95% ethanol, and the absorbance of the solution was measured at 590 nm. In this experiment, sterile liquid LB medium served as the negative control. Scanning Electron Microscopy (SEM) Overnight cultures of the three strains, AB43WT, AB43Δcro, and AB43Δcro/pcro, were used to inoculate 5 ml of LB at a 1:100 dilution and grown to OD600 = 0.5. The strains were transferred 1:100 into 12-well plates with sterile polystyrene coverslips and incubated for 24 h at 37 °C as previously described [34]. The supernatant was discarded. The pellet was then washed twice with PBS. Subsequently, 1.5 ml of 2.5% glutaraldehyde was added to fix the bacteria overnight. The fixative was discarded, washed 3 times with PBS, and dehydrated using gradients of ethanol (30, 50, 70, 80, 90, 95, and 100%) for 15 min each. After drying at the critical point, the samples were uniformly coated with double-sided conductive carbon tape and placed on aluminium sample holders for gold spraying as described previously [20]. A Gemini SEM 300 field emission scanning electron microscope (FESEM) was employed to visualize the biofilms present above, at, and below the liquid-air interface, following a previously described method [20]. Assay of adhesion and invasion Human non-small cell lung cancer cell line A549 was seeded in 24-well plates and cultured in RPMI-1640 complete medium supplemented with 10% fetal bovine serum and 1% penicillin–streptomycin at 37 °C under 5% CO₂ until reaching confluence. The medium was then aspirated, and the cells were washed three times with PBS. Each well contained approximately 3 × 10⁵ cells. Bacteria were resuspended in 2% fetal bovine serum and added to the cells at a multiplicity of infection (MOI) of 100:1. After 2 h of co-incubation, the medium was removed, and the cells were washed three times with PBS to remove non-adherent extracellular bacteria. Subsequently, 1 ml of RPMI-1640 medium containing 500 µg/ml gentamicin was added and incubated for 15 min to eliminate any remaining extracellular bacteria. Following the removal of the gentamicin-containing medium, the cells were washed three times with PBS. Next, 1 ml of freshly prepared sterile 0.1% Triton X-100 was added to each well and incubated for 10 min to lyse the cells and release intracellular bacteria. The lysates were serially diluted and plated on LB agar for bacterial enumeration, with the resulting colony counts representing the number of invasive bacteria. To determine the total number of adherent and invasive bacteria, after the 2 h co-incubation, the medium was aspirated and the cells were washed three times with PBS. Then, 1 ml of freshly prepared sterile 0.1% Triton X-100 was added directly to each well, incubated at 37 °C for 10 min, and mixed thoroughly by pipetting. The suspensions were serially diluted and plated on LB agar for colony counting, which reflected the total adherent and invasive bacterial load. The number of adherent bacteria was calculated as follows: Adherent bacteria = Total adherent and invasive bacteria − Invasive bacteria. Infection model of Galleria mellonella Survival was evaluated in a G. mellonella infection model, as previously described [35], Healthy G. mellonella larvae with milky white bodies and without grey-black patches were selected and resuscitated in a constant temperature incubator at 37 °C for 30 min, and then randomly divided into four groups of 10 worms each. G. mellonella larvae were injected with approximately 2 × 10⁵ CFU of the AB43WT, AB43Δcro, or AB43Δcro/pcro strains, respectively. For control purposes, an equal volume of saline was concurrently injected into a separate group of larvae. Injected larvae were maintained statically at 37 °C in Petri dishes and assessed for mortality every 12 h. A Kaplan-Meier survival analysis was subsequently performed using GraphPadPrism5. Mouse pneumonia model Female BALB/c mice (eight-week-old) purchased from the Comparative Medicine Research Institute of Yangzhou University were housed under standard conditions. All procedures involving animals followed the Guide for the Care and Use of Laboratory Animals. The study protocol was specifically reviewed and approved by the Ethical Committee of Yangzhou University (Approval No. 202503309). We strictly adhered to all relevant ethical guidelines for animal research. Neutropenia was induced in mice by cyclophosphamide treatment, as described previously [35]. Briefly, AB43WT, AB43Δcro, and AB43Δcro/pcro, was infected neutropenic mice with 1 × 107 CFUs of bacteria by tracheal puncture. Blank control group was injected with PBS. Survival of the mice was monitored at 4 h intervals. To assess bacterial loads and histological changes in the lungs, neutropenic mice were intratracheally inoculated with 5 × 10⁶ CFU of A. baumannii. At 48 h post-infection, surviving mice were deeply anesthetized via inhalation of isoflurane (3–5% concentration) until completely unconscious, followed by euthanasia through cervical dislocation. This method ensured rapid and painless death while avoiding chemical interference with subsequent tissue analyses. Both lungs were then aseptically removed. The right lung was homogenized and plated on LB agar plates to determine colony-forming units (CFUs), while the left lung tissue was fixed in formalin solution for subsequent hematoxylin and eosin (H&E) staining. Cloning, expression and purification of AbCro The cloning, expression, and purification of AbCro protein were performed according to methods described in references [36]. The brief procedure is as follows, the coding sequence of the Abcro was amplified using specific primers. The purified PCR product was ligated into the pET-28a (+) vector, which had been digested with EcoRI and XhoI, using T4 DNA ligase (Takara Bio, Dalian, China). The resulting recombinant plasmid was constructed and subsequently transformed into E. coli BL21(DE3) competent cells. A single colony was selected, inoculated, and cultured until the OD600 of the bacterial culture reached 0.5–0.6. Isopropyl β-D-1-thiogalactopyranoside (IPTG) was then added to a final concentration of 1 mM to induce protein expression at an appropriate temperature. After cell lysis, the recombinant AbCro protein containing a 6×His tag was purified using nickel-nitrilotriacetic acid (Ni-NTA) affinity chromatography. The purity of the protein was assessed by 15% sodium dodecyl sulfate–polyacrylamide gel electrophoresis (SDS-PAGE). Electrophoretic mobility shift assay Approximately 200 bp promoter fragments containing putative C/TT/G/CCAG/A/TCAAT/A motifs were amplified from genomic DNA using unlabeled primers (Table S1). The sequences of the synthesized mutant DNA probes are listed in Document S1. These PCR products served as templates to synthesize Cy5-labeled probes using a Cy5-conjugated primer, as previously described [37]. Binding reactions (30 µl) were assembled containing 1× binding buffer (20 mM Tris-HCl, 5% glycerol, 0.04 g/ml BSA and 0.2 M MgCl₂), 50 ng of Cy5-labeled probe (or mutant probe), 1.5 µg of salmon sperm DNA, and purified AbCro protein as specified. After incubation at 37 °C for 30 min, the samples were resolved on a 5% native polyacrylamide gel in 1× TBE buffer (pH 8.3). Cy5 signals were visualized using a VILBER FUSION-FX6.EDGE imaging system. Where indicated, unlabeled competitor DNA was included in the reaction. Transcriptomic analysis and qRT-PCR Bacterial strains were cultured in liquid LB medium to the early exponential phase. Cell pellets were harvested, washed twice with sterile water, immediately flash-frozen in liquid nitrogen, and stored at − 80 °C until RNA extraction. Total RNA from each sample was extracted using Invitrogen TRIzol® Reagent. After quality assessment, 1 µg of total RNA was subjected to ribosomal RNA removal using a prokaryotic rRNA probe kit (E-GENE), followed by treatment with RNase-free DNase I (NEB) for 30 min according to the manufacturer’s protocol. Library preparation was then initiated by fragmenting the rRNA-depleted RNA to approximately 150 bp. The cleaved RNA fragments were reverse-transcribed into double-stranded cDNA using SuperScript II (Invitrogen), RNase H (NEB), and DNA Pol I (Enzymatics) with random priming. After purification, the cDNA was subjected to end-repair, phosphorylation using T4 DNA polymerase, Klenow DNA polymerase and T4 PNK, and 3′-adenylation using Klenow Exo-(Enzymatics). Illumina sequencing adapters were ligated to the ends of the adenylated cDNA fragments, followed by purification. Finally, PCR amplification was performed to complete the library construction. Libraries were analyzed on an Agilent Bioanalyzer (Agilent Technologies, USA), quantified by real-time PCR, and sequenced on an Illumina NovaSeq 6000 platform (Illumina, USA). Differentially expressed genes were defined with thresholds of foldchange > 2 and P value < 0.05. Differential expression analysis of the RNA-seq data was performed using DESeq2, with multiple-testing correction based on the false discovery rate (FDR). RNA isolation, mRNA purification, cDNA synthesis and sequencing were conducted by E-GENE TECH Co., Ltd. All samples were evaluated with three biological replicates [38]. Following overnight culture, A. baumannii was diluted 1:100 into fresh LB and grown to OD600 = 0.5. RNA was extracted (RNA prep Pure Bacteria Kit, TIANGEN), quantified (Nanodrop), and normalized to equal concentrations. cDNA was synthesized from 1 µg RNA using the Prime Script RT Kit with gDNA Eraser (TaKaRa). qRT-PCR reactions (10 ng cDNA template) were run in triplicate on a 7500 Fast system (Applied Biosystems) with SYBR Green I detection. Expression levels were normalized to 16 S rRNA and analyzed via the 2−ΔΔCt method. Results AbCro is vital for biofilm formation by A. baumannii To investigate the role of AbCro in regulating the virulence of Acinetobacter baumannii, a gene deletion mutant was constructed in this study (Fig. S1). Growth curve analysis showed no significant differences in growth kinetics among the wild-type (AB43WT), the wild-type strain carrying an empty vector (AB43WT/empty vector), the Abcro mutant (AB43Δcro), the mutant carrying an empty vector (AB43Δcro/empty vector), and the complemented strain (AB43Δcro/pcro). These results indicate that the empty vector itself has no effect on bacterial growth, and that deletion of the Abrco gene does not affect the normal growth of A. baumannii (Fig. 1A). Quantitative real‑time PCR confirmed successful restoration of Abcro expression in the AB43Δcro/pcro strain (Fig. 1B). Next, to assess whether the deletion of Abcro could affect biofilm formation of A. baumannii, biofilm formation was quantified using a crystal violet assay. The results revealed a striking attenuation of biofilm in the AB43Δcro, with biomass reduced by 70.5% relative to AB43WT and by 66.9% relative to AB43Δcro/pcro (Fig. 1C). AbCro is vital for biofilm formation by A. baumannii. A Growth curves of the AB43WT and its derivative strains in LB broth. B qRT-PCR analysis confirmed expression changes of Abcro. C Quantification of AB43WT and its derivative strains biofilm formation by crystal violet staining. D SEM analysis of bacterial biofilms formed on plastic surfaces at the liquid-air interface. P values were determined by two-tailed Student’s t test, *p < 0.05, **p < 0.01, ***p < 0.001 To further characterize biofilm architecture, we performed scanning electron microscopy (SEM) on plastic surfaces at the liquid-air interface. The AB43WT demonstrated a robust capacity for surface attachment and formed mature, distinctive biofilms across the analyzed areas, including the liquid-air interface. In contrast, the AB43Δcro produced substantially simpler and sparser cellular aggregates at the liquid-air interface. Biofilm architecture was restored to a wild-type-like structure when the mutant was complemented with a plasmid carrying the parental Abcro allele (Fig. 1D). These SEM observations are consistent with the quantitative data obtained from the crystal violet assays. AbCro increases virulence of A. baumannii The finding that Abcro deletion reduces biofilm formation led us to suspect a concurrent attenuation in virulence, given the established role of biofilms in pathogenicity. A crucial aspect of virulence is the capacity to adhere to and invade host cells. We therefore examined these functions in AB43Δcro, focusing on epithelial cells, which constitute the primary defensive barrier of the human body and are a key target for A. baumannii invasion [35]. In order to characterize these virulence-associated properties, in vitro infection assays were conducted with A549 human alveolar epithelial cells as the host model [7, 39]. Infection of confluent monolayers was performed at an MOI of 100 using the three isogenic strains (AB43WT, AB43Δcro, and AB43Δcro/pcro), which was followed by the quantitative determination of bacterial adhesion and invasion. As shown in Fig. 2A and B, compared with AB43WT and AB43Δcro/pcro, the adhesive and invasive capacities of the AB43Δcro were significantly impaired. AbCro is crucial for the virulence of A. baumannii. A Adhesion rate to A549 cells. B Invasion rate to A549 cells. C Survival rates of G.mellonella larva. Infected larvae (n = 10) with 10 µl (2.0 × 105 CFU) AB43WT, AB43Δcro, and AB43Δcro/pcro strains at the right posterior gastropoda. D Survival rates of mouse. For mouse infection (n = 10) with 10 µl (1.0 × 107 CFU) AB43WT, AB43Δcro, and AB43Δcro/pcro strains by tracheocentesis. P values were determined by two-tailed Student’s t test, *p < 0.05, **p < 0.01, ***p < 0.001 The effect of AbCro on A. baumannii virulence was evaluated using a G. mellonella infection model. In this model, the AB43Δcro showed significantly reduced virulence relative to AB43WT. As shown in Fig. 2C, at 96 h post-infection, the larval survival rate was 30% following infection with AB43WT, whereas it increased to 70% in the group infected with the AB43Δcro. The survival rate after infection with the AB43Δcro/pcro was comparable to that of AB43WT, indicating that restoration of AbCro function partially restored bacterial virulence. These results suggest that deletion of the Abcro significantly attenuates the virulence of A. baumannii. To further verify the role of AbCro in virulence, we employed a murine pneumonia model. Mice were infected via transtracheal injection with 1 × 10⁷ CFU of bacteria and monitored for 120 h. As shown in Fig. 2D, AB43WT infection resulted in 40% mortality within the first 48 h. In contrast, the AB43Δcro mutant was markedly less virulent, with approximately 70% of mice succumbing to infection over the entire observation period. Moreover, the mortality kinetics were delayed by more than 12 h in the mutant group. The complementation strain had a final survival rate of 10% and the kinetics of death in mice were similar to those of the wild strain. Collectively, our findings demonstrate that Abcro significantly contributes to the virulence of A. baumannii. AbCro regulates A. baumannii’s pathogenesis in vivo Using intratracheal injection, we developed a mouse pneumonia model to evaluate the function of AbCro. BALB/c mice were infected with the AB43WT, AB43Δcro, and AB43Δcro/pcro strains separately. As shown in Fig. 3A, While AB43WT infection induced significant pneumonia within 48 h, injury was substantially milder in AB43Δcro-infected mice. AB43Δcro/pcro restored AB43WT strain pathology, corroborating the in vitro virulence data. Uninfected control lungs appeared normal in color and morphology. Lung histology was further evaluated by H&E staining. As shown in Fig. 3B, histopathological examination revealed prominent inflammatory cell infiltration (neutrophils and lymphocytes), bronchial epithelial denudation, and focal alveolar hemorrhage, suggesting acute pulmonary injury with epithelial damage and microvascular leakage. AbCro reduced the pathogenicity of A. baumannii in mice. A Gross lesion observation of lungs of mice infected with the AB43WT, AB43Δcro, and AB43Δcro/pcro strain. B H&E analysis of lungs of mice infected with the AB43WT, AB43Δcro, and AB43Δcro/pcro strain. C Bacterial load determinations for the WT and its derivatives in infected lungs at 48 h postinfection. P values were determined by two-tailed Student’s t test, *p < 0.05, **p < 0.01, ***p < 0.001 Histopathological analysis of infected mouse lungs revealed that the alveolar spaces in both AB43WT and AB43Δcro/pcro complementation strains were densely infiltrated by neutrophils, accompanied by bronchial epithelial denudation and focal alveolar hemorrhage. No significant injury was observed in AB43Δcro-infected or uninfected mice, which aligned with H&E staining results. For bacterial quantification, lung homogenates were prepared from all infection groups (AB43WT, AB43Δcro, and AB43Δcro/pcro). AB43Δcro exhibited a significantly reduced bacterial load (2.95 ± 0.99 log₁₀ CFU), approximately 2–3 log₁₀ units lower than AB43WT (5.82 ± 0.88 log₁₀ CFU) and AB43Δcro/pcro (4.86 ± 0.8 log₁₀ CFU) (Fig. 3C). These findings demonstrate that AbCro is required for high-titer infection and tissue injury, confirming its role in enhancing A. baumannii virulence in mice. Downregulation of virulence-related genes in AB43Δcro Transcriptomic analysis was conducted to delineate the role of AbCro in biofilm and virulence regulation. RNA-seq was performed on AB43WT versus the AB43Δcro, and differential expression of candidate genes was confirmed by qRT-PCR. Prior to RNA extraction, bacterial cells were cultured under standard conditions (37 °C, 220 rpm) and harvested at the logarithmic phase (18 h). Compared to the AB43WT strain, 70 genes were upregulated and 102 genes were downregulated in the AB43Δcro strain, the threshold value of differentially expressed genes was a fold change of>2 and a P value of <0.05 (Dataset S1, Fig. 4A). RNA-seq showed that the expression of some virulence-related genes was significantly downregulated of the AB43Δcro mutant strain compared to AB43WT strain. As shown in Fig. 4B, for example, surface antigen protein 1, surA1 (K9O37_RS07405) [40], Catalase HPII, katE (K9O37_RS07425) [41, 42], SDR family oxidoreductase (K9O37_RS07430) [43] and Glycosyltransferase (K9O37_RS11980) [44] were downregulated of the AB43Δcro mutants strain compared to AB43WT strains. In addition, trehalose-phosphatase, otsB (K9O37_RS14615) and trehalose-6-phosphate synthase, otsA (K9O37_RS14620) [27, 45] were downregulated of the AB43Δcro mutants strain compared to AB43WT strains. the deletion of Abcro has a profound impact on virulence-associated genes. A Differential gene volcano map. B RNA-seq explored partially selected genes with decreased expression in AB43Δcro strains relative to control strain. C qRT-PCR analysis confirmed expression changes of some selected genes. P values were determined by two-tailed Student’s t test, *p < 0.05, **p < 0.01, ***p < 0.001 qRT-PCR analysis confirmed that surA1, katE, K9O37_RS07430, K9O37_RS11980, otsA, otsB, were downregulated in the AB43Δcro strain compared to AB43WT strains. (Fig. 4C). To visually validate the differential expression observed in our transcriptomic analysis, we examined the RNA-seq read coverage across the otsB, and otsA as a representative example (Fig. S4). Consistent with the quantitative data presented in Fig. 4B and C, the read density in the AB43Δcro mutant was markedly reduced across both otsB and otsA compared to the parental AB43WT strain. This visualization provides further confirmation that disruption of Abcro leads to a profound transcriptional downregulation of the entire otsBA operon. By integrating RNA-seq and RT-PCR data analysis, it was found that, in addition to otsB, and otsA, a group of genes involved in different virulence-related processes showed coordinated downregulation (Fig. 4B, C). These comprised surA1, which contributes to outer membrane protein biosynthesis and stress resistance [40], katE, encoding a catalase that helps counteract the host oxidative burst [41], as well as genes encoding an SDR-family oxidoreductase, potentially involved in detoxification, and a glycosyltransferase, which may function in surface polysaccharide modification [43, 44]. This expression pattern suggests that AbCro may act as a pleiotropic regulator, coordinating a virulence network that extends beyond trehalose metabolism and includes pathways such as oxidative stress defense and maintenance of cell surface integrity. The concurrent impairment of these pathways likely collectively contributes to the severe attenuation of the Abcro mutant observed in biofilm formation and in vivo infection models. AbCro binds to the promoters of genes related to trehalose synthesis pathway Analysis of RNA-seq data revealed two differentially expressed genes, namely otsA and otsB, encoding 284 and 477 (respectively) amino acids proteins. The otsA is located downstream of otsB, with an overlap of 13 nucleotides between the two genes. (Fig. 5A). We used electrophoretic mobility shift assays (EMSAs) to examine AbCro binding to promoter fragments of potential target genes. In E. coli, the enzymes OtsA and OtsB are known to sequentially catalyze trehalose synthesis from UDP-glucose and glucose-6-phosphate, suggesting a conserved regulatory point for AbCro [46]. The encoding genes have been nucleotide sequenced and shown to be organised into an operon (otsBA). This genomic organization is similar to that reported in E. coli [46]. Based on this conserved structure, the otsA and otsB in A. baumannii likely form a single transcriptional unit, designated the otsBA operon. Directly regulated target genes of AbCro in A. baumannii. A Locations of the otsA and otsB open reading frames. B The AbCro binding motif was identified using MEME Suite analysis. C Sequence and structural characterization of AbCro-protected otsBA promoter region. C/TT/G/CCAG/A/TCAAT/A motif in the AbCro binding sites of otsBA are show in red font. The underscore indicates the probe length. D EMSA of Cro binding to the Cy5 labeled promoter fragments of otsBA. EMSA was performed by incubating the indicated amounts of purified AbCro protein with a Cy5-labeled DNA fragment containing the C/TT/G/CCAG/A/TCAAT/A motif or a mutant motif instead of C/TT/G/CCAG/A/TCAAT/A. Competition was achieved by adding unlabeled probe (cold) To validate the downstream genes regulated by transcription factors, obtained the His-tagged recombinant protein AbCro for use in EMSA (Fig. S2). Through multiple sequence motif extraction (MEME) of the promoter regions of differentially expressed genes, the AbCro DNA-binding motifs were identified (Table S2, Fig. 5B). To characterize the conserved sequence of AbCro binding to the otsBA promoter, we analyzed potential sequences within the 300 bp upstream of the annotated translation initiation codon based on the transcription start site. Palindromic sequence alignment based on AbCro reveals multiple sequences highly similar to the predicted DNA motif within the − 207site range of the otsBA promoter region (Fig. 5C). We speculated that AbCro might regulate the expression of otsBA by binding to this DNA motif. To test this speculation, we performed the EMSA analysis. As shown in Fig. 5D, AbCro clearly interacted with Cy5-labeled promoter fragment (probe) with the “C/TT/G/CCAG/A/TCAAT/A” motifs, otsBA. The binding was competitively inhibited by excess unlabeled wild-type probe (lanes 5–7), demonstrating specificity. Furthermore, binding was abolished when the predicted core motif was replaced with a random sequence (lane 8), suggesting this region is necessary for AbCro interaction. Consistent with this direct interaction, RNA-seq and qRT-PCR analyses demonstrate that AbCro positively regulates the expression of otsA and otsB, suggesting its likely role as a direct transcriptional activator. To directly assess the contribution of the trehalose biosynthesis pathway to pathogenicity in the model system, we constructed an AB43ΔotsBA strain in the AB43 genetic background. Compared with the AB43WT strain, infection of G. mellonella larvae with the AB43ΔotsBA strain resulted in a significantly higher larval survival rate (Fig. S3). This attenuated virulence phenotype is consistent with that observed for the AB43Δcro strain. Discussion This study establishes AbCro, a Cro/CI family transcription factor in A. baumannii, as a novel phage-derived virulence regulator. We demonstrate that AbCro likely functions as a transcriptional activator of the otsBA operon, and this pathway serves as a primary mechanism through which it enhances bacterial virulence. Our findings extend beyond the established role of Cro proteins in phage lysogenic-lytic cycles [28] and reports of their function in EHEC [30], revealing a conserved yet functionally repurposed role for these phage-derived regulators in rewiring bacterial transcriptional networks to enhance pathogenicity. The AB43Δcro strain exhibited significantly reduced biofilm formation in vitro and displayed markedly attenuated virulence in a mouse pneumonia model, highlighting the critical role of AbCro in pathogenicity. Transcriptomic analysis revealed significant downregulation of both otsA and otsB, indicating that the trehalose biosynthesis pathway is likely a key target. The otsA is located at the 3’ end of otsB, with the two genes arranged in a 13-nucleotide overlapping configuration. This structural organization is consistent with observations in E. coli and Salmonella enterica serovar Typhimurium, suggesting that otsBA in A. baumannii likely forms a single transcriptional unit—the otsBA operon [46, 47]. EMSA confirmed that the AbCro protein specifically binds to a newly identified DNA motif (“C/TT/G/CCAG/A/TCAAT/A”) within the otsBA promoter region, likely directly regulating this downstream target gene. Together, this cascade of evidence, from phenotypic validation and transcriptomic analysis to DNA-binding assays, establishes AbCro as a likely direct positive regulator of the otsBA operon. We therefore conclude that the activation of the otsBA-dependent trehalose biosynthesis pathway constitutes a key, though likely not exclusive, mechanism by which AbCro enhances virulence. To further verify that the otsBA operon serves as the key functional effector downstream of AbCro, we constructed a AB43ΔotsBA mutant. Infection of G. mellonella with this mutant revealed a virulence-attenuated phenotype that closely phenocopied that of the AB43ΔAbcro strain, whereas complementation restored AB43WT virulence. These results further confirm that the trehalose biosynthesis pathway represents the predominant regulatory route through which AbCro enhances the virulence of A. baumannii. Based on our findings, we propose a model in which AbCro acts as a transcriptional activator of the otsBA operon, upregulating its expression. The otsBA operon encodes two key enzymes, trehalose-6-phosphate synthase (OtsA) and trehalose-6-phosphate phosphatase (OtsB) that function sequentially to synthesize trehalose, a critical stress-response metabolite. OtsA first utilizes UDP-glucose and glucose-6-phosphate to produce trehalose-6-phosphate, followed by OtsB-mediated dephosphorylation that yields the final product, trehalose [26, 27, 46–49]. As a critical stress protectant [38], the accumulated trehalose enhances bacterial stress tolerance through multiple molecular mechanisms - stabilizing macromolecular structures via formation of a vitrified matrix while maintaining intracellular membrane integrity through osmotic adjustment. These properties enable the bacteria to effectively counteract host-induced stresses in the pulmonary microenvironment, including hyperosmotic pressure and oxidative damage triggered by immune cell-derived reactive oxygen species [50]. This enhanced environmental adaptability significantly improves bacterial colonization efficiency and survival at infection sites, ultimately manifesting as more severe tissue damage and systemic infection in our mouse pneumonia model, successfully recapitulating the pathogenic process of clinical infection [28, 51]. This mechanistic model is supported by multiple independent studies, previous investigations have demonstrated that deficiencies in otsA or otsB result in trehalose auxotrophy and profound virulence defects that phenocopy the AB43Δcro mutant [26, 27, 47], thereby providing genetic validation of the central role of the AbCro-otsBA-trehalose pathway in virulence regulation. This study has certain limitations, while also highlighting potential directions for future research. First, our investigation was primarily conducted under specific experimental conditions and established the correlative and mechanistic links between AbCro, the otsBA operon, and virulence in only a single clinical strain. Although complementation experiments and in vitro binding assays support a direct regulatory role, the precise molecular details of how AbCro activates otsBA transcription remain to be fully elucidated. Moreover, although this study has confirmed that otsBA is a key downstream target of AbCro, the detailed phenotype of the AB43ΔotsBA mutant in mammalian infection models and biofilm formation awaits further confirmation. For instance, future research could employ methods such as construction of otsBA-gfp fusion transcriptional reporter strains, and constitutive overexpression assays to further elucidate the dynamic regulatory process of AbCro on otsBA transcription. Second, although EMSA demonstrated specific binding of AbCro to the otsBA promoter, further validation through in vivo approaches such as chromatin immunoprecipitation sequencing (ChIP-seq) is lacking to strengthen these conclusions. Third, the functional conservation of AbCro across diverse A. baumannii strains and its prevalence in clinical settings remain unknown. Investigating the sequence variability of AbCro and its association with virulence phenotypes in a broader collection of strains would help clarify its epidemiological significance. Finally, the translational potential of targeting AbCro requires further exploration. Although our findings nominate AbCro as a potential anti-virulence target, the relationship between Abcro expression levels and the severity of human infections, as well as the development and efficacy of specific inhibitors, remains to be investigated. In addition, although the recombinant AbCro protein used in this study was not verified by mass spectrometry, SDS-PAGE analysis showed that the purified protein appeared as a single clear band with the expected molecular weight (Fig. S2). We acknowledge this technical limitation and will perform mass spectrometry validation for all key recombinant proteins in future studies. Addressing these limitations in future work will be crucial for comprehensively understanding the regulatory network governed by AbCro and evaluating its therapeutic applicability. In summary, our work elucidates a novel pathway in which A. baumannii has co-opted a phage-derived transcription factor, AbCro, to augment its virulence by activating a central stress-responsive metabolic pathway. This evolutionary adaptation highlights the role of horizontal gene transfer in the emergence of bacterial pathogenicity. Given the critical function of AbCro and the absence of its homologs in mammals, targeting this phage-derived regulator represents a promising strategic avenue for developing novel anti-virulence therapies against multidrug-resistant A. baumannii infections. Supplementary Information Supplementary Material 1: Fig S1. Generation of Abcro-knockout and complemented strains from A. baumannii. (A) Nucleic acid electrophoresis map of marker (Line M) and upstream and downstream DNA fragment of Abcro (Line 1), and (Line 2), the kanamycin resistance gene (Line 3) and kanamycin resistance gene linked with the homologous recombination upstream and downstream DNA fragment of Abcro (Line 4). (B) the Abcro was successfully replaced by the kanamycin resistance gene and could be amplified from the correct clone 1st, 3rd, and 5th, and final elimination of the kanamycin gene and verification of the absence of the kanamycin gene 2nd, 4th, and 6th by PCR using primers Abcro-out forward/reverse and the marker (Line M). (C) Nucleic acid electrophoresis map of Abcro in E. coli and A. baumannii using primers pMMB67EH-F/pMMB67EH-R (Line 1, Line 2, Line 3, Line 4, Line 5, Line 6, Line 7) and the marker (Line M). Supplementary Material 2: Fig S2. SDS-PAGE analysis of heterologous expression and purification of the recombinant protein AbCro in E. coli BL21(DE3). Lanes: M, standard protein molecular weight markers; 1, Crude extract supernatant of E. coli BL21(DE3) harboring the empty pET-28a vector (negative control); 2, Crude extract supernatant of E. coli BL21(DE3) harboring the recombinant plasmid (pET-28a-AbCro) after induction with 1 mM IPTG at 37°C for 6 h; 3, The recombinant protein AbCro purified by Ni-NTA affinity chromatography. Supplementary Material 3: Fig S3. otsBA is crucial for the virulence of A. baumannii. Survival rates of G.mellonella larva. Infected larvae (n = 10) with 10 μl (2.0×105 CFU) AB43WT, AB43ΔotsBA, and AB43ΔotsBA/potsBA strains at the right posterior gastropoda. Supplementary Material 4: Fig S4. RNA-seq profile of theotsBandotsA. Coverage tracks show RNA-seq reads from the AB43 (upper panel) and the AB43Δcromutant (lower panel) mapped to theotsBandotsAregions. Scale bar, 0.5 kb. Supplementary Material 5. Supplementary Material 6. Authors’ contributions C.L. Writing – Methodology, Investigation, Data curation, Conceptualization. A. Q. Visualization, Methodology, Data curation. J.X. and M.F. Visualization, Methodology, Data curation. J.W., C.G. and W.Y. Methodology, Funding acquisition. J.W., J.H. and T.Y. Methodology. J.H. Supervision, Investigation, Funding acquisition, W.Y. Investigation, Data curation. G.L. Validation, Supervision, Data curation, Conceptualization, Funding acquisition. Funding This work was supported by grants from the National Natural Science Foundation of China (82373637, and 82073611), the Natural Science Foundation of Jiangsu Province (BK20231241, and BK20250893), the Wuxi Commission of Health Science Foundation (M202424), the Jiangsu Commission of Health Science Foundation (ZQ2024025), the Yangzhou Health Commission medical research projects (2025226), the Jiangsu Provincial Department of Science and Technology (H2023119), the PhD research startup foundation of the Third Affiliated Hospital of Zhengzhou University (BS20210103). Data availability RNA-sequencing data have been deposited in the National Center for Biotechnology Information (NCBI) sequence read archive (SRA) database (PRJNA1327475). Declarations Ethics approval and consent to participate All experimental procedures were conducted in accordance with the Guide for the Care and Use of Laboratory Animals and were approved by the Ethical Committee of Yangzhou University (approval number: 202503309). Consent for publication Not applicable. Competing interests The authors declare no competing interests. Footnotes Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations. Cuicui Liu, Ao Qin, Jun Xie and Mingpeng Fu contributed equally to this work. Contributor Information Jian Hu, Email: yxszyyy795@163.com. Weixuan Yang, Email: ywx15861719531@yzu.edu.cn. Guocai Li, Email: gcli@yzu.edu.cn. References Associated Data Supplementary Materials Supplementary Material 1: Fig S1. Generation of Abcro-knockout and complemented strains from A. baumannii. (A) Nucleic acid electrophoresis map of marker (Line M) and upstream and downstream DNA fragment of Abcro (Line 1), and (Line 2), the kanamycin resistance gene (Line 3) and kanamycin resistance gene linked with the homologous recombination upstream and downstream DNA fragment of Abcro (Line 4). (B) the Abcro was successfully replaced by the kanamycin resistance gene and could be amplified from the correct clone 1st, 3rd, and 5th, and final elimination of the kanamycin gene and verification of the absence of the kanamycin gene 2nd, 4th, and 6th by PCR using primers Abcro-out forward/reverse and the marker (Line M). (C) Nucleic acid electrophoresis map of Abcro in E. coli and A. baumannii using primers pMMB67EH-F/pMMB67EH-R (Line 1, Line 2, Line 3, Line 4, Line 5, Line 6, Line 7) and the marker (Line M). Supplementary Material 2: Fig S2. SDS-PAGE analysis of heterologous expression and purification of the recombinant protein AbCro in E. coli BL21(DE3). Lanes: M, standard protein molecular weight markers; 1, Crude extract supernatant of E. coli BL21(DE3) harboring the empty pET-28a vector (negative control); 2, Crude extract supernatant of E. coli BL21(DE3) harboring the recombinant plasmid (pET-28a-AbCro) after induction with 1 mM IPTG at 37°C for 6 h; 3, The recombinant protein AbCro purified by Ni-NTA affinity chromatography. Supplementary Material 3: Fig S3. otsBA is crucial for the virulence of A. baumannii. Survival rates of G.mellonella larva. Infected larvae (n = 10) with 10 μl (2.0×105 CFU) AB43WT, AB43ΔotsBA, and AB43ΔotsBA/potsBA strains at the right posterior gastropoda. Supplementary Material 4: Fig S4. RNA-seq profile of theotsBandotsA. Coverage tracks show RNA-seq reads from the AB43 (upper panel) and the AB43Δcromutant (lower panel) mapped to theotsBandotsAregions. Scale bar, 0.5 kb. Supplementary Material 5. Supplementary Material 6. Data Availability Statement RNA-sequencing data have been deposited in the National Center for Biotechnology Information (NCBI) sequence read archive (SRA) database (PRJNA1327475).